Cresemba and Mucinex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cresemba (isavuconazonium sulfate) and Mucinex (guaifenesin). Common drug interactions include pneumonia among females and white blood cell count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Cresemba and Mucinex. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Cresemba?

Cresemba has active ingredients of isavuconazonium sulfate. eHealthMe is studying from 2,574 Cresemba users. Check the latest studies of Cresemba.

What is Mucinex?

Mucinex has active ingredients of guaifenesin. It is often used in cough. eHealthMe is studying from 29,749 Mucinex users. Check the latest studies of Mucinex.

On Jul, 13, 2026

15 people who take Cresemba and Mucinex together, and have interactions are studied.

What are the common drug interactions of Cresemba and Mucinex, by gender? *:

female:

Pneumonia
Acute respiratory failure
Back pain
Cystic fibrosis (disease of the secretary glands)
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Thrombocytopenia (decrease of platelets in blood)
Drug intolerance (drug sensitivity)
Electrolyte imbalance
Intestinal obstruction

male:

White blood cell count decreased
Asthenia (weakness)
Pyrexia (fever)
Red blood cell count decreased
Blood potassium increased
Fatigue (feeling of tiredness)
Febrile neutropenia (fever with reduced white blood cells)
Infection
Nausea (feeling of having an urge to vomit)
Platelet count decreased

What are the common drug interactions of Cresemba and Mucinex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Acute respiratory failure
Back pain
Cystic fibrosis (disease of the secretary glands)
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
Pneumonia
Thrombocytopenia (decrease of platelets in blood)
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Intestinal obstruction
Oral discomfort (pain or irritation in mouth)
Pain in extremity

60+:

Asthenia (weakness)
Blood potassium increased
Pneumonia pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa)
Pyrexia (fever)
Red blood cell count decreased
White blood cell count decreased
Drug intolerance (drug sensitivity)
Electrolyte imbalance
Fatigue (feeling of tiredness)
Febrile neutropenia (fever with reduced white blood cells)

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 8 people, 53.33%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 2 people, 13.33%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 6.67%
Dyspnea (difficult or laboured breathing): 1 person, 6.67%
Arthritis Infective (purulent invasion of a joint by an infectious agent which produces arthritis): 1 person, 6.67%
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 1 person, 6.67%
Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 1 person, 6.67%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 6.67%
Depression: 1 person, 6.67%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Cresemba and Mucinex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously